In microarray gene expression experiments, several diverse conditions in each experiment (e.g., time, doses, replicates) increase the data points from tens of thousands of measurements for a single ...

Over the past decade, high-throughput gene expression experiments have generated data from millions of assays. Data sets linked to publications are stored in functional genomics data archives: ...

Pancreatic ductal adenocarcinoma (PDAC) is an important cause of malignancy-related death. In the United States, it ranks fifth among the leading causes of cancer death, accounting for approximately ...

BOSTON--Gene expression microarrays have made a profound impact on biomedical research. The current expectation is that this technology will extend its current role as an experimental tool for basic ...

Although the superiority of expression-based biomarkers, as compared with traditional clinical staging, has been disputed, 33 a nationwide clinical trial is under way in the Netherlands in which ...

Statistical and Biological Review of Transcriptome Data Made Possible by Interactive Report Although bench scientists understand the value of using gene-expression microarray technology, the full ...

Integromics® has announced the launch of its OmicsOffice® platform for the analysis and integration of genomics data from NGS, qPCR and microarrays technologies. OmicsOffice is the first product ...

As a graduate student, Eric Olson learned something about DNA microarrays: Biochip data management can be vexing. His graduate adviser abandoned a number of microarray experiments because it was too ...

Expert Rev Mol Diagn. 2013;13(6):601-611. In other situations, normal microarray analysis in the presence of an abnormal karyotype, such as marker chromosomes, is reassuring, as it indicates that the ...

KFB - Center of Excellence for Fluorescent Bioanalysis, an authorized Affymetrix Service Provider, and Genomatix Software GmbH have signed a cooperation and license agreement that integrates the ...

SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today announced the release of the latest versions of its VIA™ and Solve™ software for genomic data analysis and ...